Watch for a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGLVY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for TGLVY entered a downward trend on November 25, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on December 05, 2024. You may want to consider a long position or call options on TGLVY as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for TGLVY just turned positive on December 06, 2024. Looking at past instances where TGLVY's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .
TGLVY moved above its 50-day moving average on December 05, 2024 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TGLVY crossed bullishly above the 50-day moving average on December 16, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TGLVY advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .
TGLVY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.127) is normal, around the industry mean (23.300). P/E Ratio (27.248) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.014) settles around the average of (0.018) among similar stocks. P/S Ratio (2.581) is also within normal values, averaging (43.338).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TGLVY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TGLVY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYCCX | 398.53 | 6.51 | +1.66% |
Rydex NASDAQ-100® 2x Strategy C | |||
BTEKX | 74.39 | 0.87 | +1.18% |
BlackRock Technology Opportunities K | |||
ASQCX | 14.23 | 0.08 | +0.57% |
American Century Small Company C | |||
FACPX | 43.32 | 0.15 | +0.35% |
Fidelity Advisor Consumer Discret M | |||
GEMOX | 12.01 | 0.02 | +0.17% |
Goldman Sachs Emerging Mkt Eq ex. ChnInv |
A.I.dvisor tells us that TGLVY and BNR have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TGLVY and BNR's prices will move in lockstep.
Ticker / NAME | Correlation To TGLVY | 1D Price Change % | ||
---|---|---|---|---|
TGLVY | 100% | N/A | ||
BNR - TGLVY | 20% Poorly correlated | +6.99% | ||
TRXO - TGLVY | 13% Poorly correlated | N/A | ||
SSMXY - TGLVY | 12% Poorly correlated | +0.21% | ||
VPTDF - TGLVY | 8% Poorly correlated | -3.41% | ||
TRUMY - TGLVY | 3% Poorly correlated | +0.26% | ||
More |